Lung Diseases, Obstructive: all 2,585 studies

Page 25 of 26. Open to participants first (194), then studies with results posted, then the rest; newest registration first within each.

• Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00491803Phase 4
• Feasibility and Outcomes of Older Patients HospitalizationStatus unknownNCT00489021Not applicable
• Efficacy of Average Volume Assured Pressure Support With Bi-Level Pressure Support Nocturnal VentilationCompletedNCT00479284Not applicable
• Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPDCompletedNCT00477074
• Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPDCompletedNCT00476099Phase 3
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
• Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsTerminatedNCT00467636Not applicable
• Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00465959Phase 1/2
• A Crossover Study in the Treatment of Patients With COPDCompletedNCT00462540Phase 3
• Dyspnea Self-Management: Internet or Face-to-FaceCompletedNCT00461162Phase 1/2
• Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00458419Not applicable
• Regulatory T Cells in COPDCompletedNCT00452764
• Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsCompletedNCT00448604
• Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00448500
• Inhaled Mannitol and Ciliary Beat Frequency in COPD PatientsWithdrawnNCT00446121
• The Effect of Neuromuscular Electrical StimulationCompletedNCT00442728Not applicable
• Infectious Etiology of Acute Exacerbations of COPDCompletedNCT00441389
• Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary CareCompletedNCT00440687Phase 4
• Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00435760Phase 3
• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)CompletedNCT00430729Phase 3
• Non-invasive Ventilation Versus Sham Ventilation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00429156Phase 3
• Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00422604Phase 2
• Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPDCompletedNCT00421122Phase 3
• Optimizing the Effect of COPD RehabilitationStatus unknownNCT00419289Not applicable
• A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)CompletedNCT00418613Phase 2
• Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD) ExacerbationTerminatedNCT00413543Not applicable
• The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPDCompletedNCT00406705Phase 2
• Effect of Tiotropium on Inflammation and Exacerbations in COPDCompletedNCT00405236Phase 4
• Protocol Chronic Obstructive Pulmonary DiseaseCompletedNCT00404430
• A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00403286Phase 2
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00396604Phase 2/3
• Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary DiseaseCompletedNCT00394940
• Helium-Hyperoxia and 6MWT Distance in COPDCompletedNCT00394225Not applicable
• A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT00392587Phase 2
• A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart FailureWithdrawnNCT00384566Phase 4
• Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00384306Phase 1
• Breath Actuated Nebulizer Study ProtocolWithdrawnNCT00382447Not applicable
• A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00380796
• Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00379730Phase 1
• Airway Clearance StudyCompletedNCT00379028Phase 4
• SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00361959Phase 4
• Chronic Obstructive Pulmonary Disease Endpoints StudyCompletedNCT00358358Phase 4
• Chronic Obstructive Pulmonary Disease and Weaning From Mechanical Ventilation in Difficult to Wean PatientsCompletedNCT00355732Phase 4
• Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00354354Phase 4
• ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.TerminatedNCT00346749Phase 4
• Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseCompletedNCT00345774Phase 2
• Phase 2 Study - Erdosteine in Patients With CB/COPDCompletedNCT00338507Phase 2
• Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00335621Phase 4
• Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure.Status unknownNCT00331656Phase 4
• Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary DiseaseCompletedNCT00328484Phase 3
• Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and TracheostomyTerminatedNCT00323986Phase 2
• COPD Rehabilitation in Primary and Secondary Health CareStatus unknownNCT00320333
• Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary DiseaseStatus unknownNCT00317057Not applicable
• Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT00316992Phase 4
• Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00311961Phase 4
• Macrophages in Smokers' LungWithdrawnNCT00298402
• Relative Potency of Inhaled CorticosteroidsCompletedNCT00292838Phase 4
• Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPDWithdrawnNCT00291408Phase 4
• Use of the Hattler Respiratory Assist Catheter in Severe Respiratory FailureWithdrawnNCT00288964Phase 3
• Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00288548Phase 4
• Early Pulmonary Rehabilitation for Hospitalized Patients With Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00287625Not applicable
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
• Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT00281242
• T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT00281229
• Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease ExacerbationsCompletedNCT00281216
• Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPDCompletedNCT00281203
• Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary FunctionCompletedNCT00281190
• Towards Restoring the Physiological Inhibition of Airway Narrowing in AsthmaStatus unknownNCT00279136
• Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
• Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274092Phase 3
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00268216Phase 3
• Airway Inflammation In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00268177Phase 3
• Sodium Pyruvate Therapy in COPD PatientsCompletedNCT00262613Phase 2
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00259909
• Comparison Between Symbicort® and Prednisolone in COPDCompletedNCT00259779Phase 3
• Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)CompletedNCT00246935Phase 3
• Effects of Temazepam in Patients With Chronic Pulmonary Obstructive DiseaseCompletedNCT00245661Phase 3
• Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of LifeCompletedNCT00243282Not applicable
• Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)CompletedNCT00242320Phase 3
• Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)CompletedNCT00242294Phase 2/3
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239434Phase 3
• A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239421Phase 4
• Budesonide / Formoterol in Treatment of Exacerbations of COPDCompletedNCT00239278Phase 2
• Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health NetworksStatus unknownNCT00238836Phase 2/3
• Evaluating Genes in Sputum to Measure Drug Response in COPDTerminatedNCT00233051Not applicable
• Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
• Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ?TerminatedNCT00221819Not applicable
• Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00219648Phase 2
• A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00219622Phase 2
• Study in Patients With COPDCompletedNCT00215423Phase 2
• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDCompletedNCT00206167Phase 3
• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsCompletedNCT00206154Phase 3
• Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202189Phase 4
• Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202176Phase 4
• Primary Care Management/Action Plans for Advanced Chronic DiseasesCompletedNCT00202150Phase 2/3
• ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPDCompletedNCT00190437Phase 4
• How Smoking Causes COPD: Examination of Immune System ChangesStatus unknownNCT00186719
• Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00186706Phase 4
• COPD on Primary Care Treatment (COOPT)CompletedNCT00184977Phase 4

← Lung Diseases, Obstructive overview